Suppliers and packages for tradename: APRISO
✉ Email this page to a colleague
APRISO
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-9224-89 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-9224-89) | 2021-01-05 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-884-79 | 2160 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43353-884-79) | 2008-10-31 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA AUTHORIZED GENERIC | Bryant Ranch Prepack | 63629-8827-1 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-8827-1) | 2021-01-05 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA | Salix Pharmaceuticals, Inc. | 65649-103-01 | 1 BOTTLE in 1 CARTON (65649-103-01) / 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2008-10-31 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA | Salix Pharmaceuticals, Inc. | 65649-103-02 | 1 BOTTLE in 1 CARTON (65649-103-02) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2008-10-31 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceuticals | 68682-113-20 | 1 BOTTLE in 1 CARTON (68682-113-20) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2018-07-19 |
| Salix | APRISO | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 022301 | NDA AUTHORIZED GENERIC | Lupin Pharmaceuticals, Inc. | 70748-214-16 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-214-16) | 2020-05-18 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
